What is Cormark's Forecast for kneat.com FY2027 Earnings?

Key Points

• Cormark has increased its FY2027 earnings per share estimate for kneat.com from $0.08 to $0.09, despite the current consensus estimate being a loss of ($0.12) per share.
• Raymond James Financial has downgraded its price target for kneat.com from C$7.50 to C$7.00 while maintaining an "outperform" rating on the stock.
• The stock currently has an average rating of "Buy" with a consensus price target of C$6.50 and is trading at C$5.90, showing an increase of 0.9% recently.

kneat.com, inc. (TSE:KSI - Free Report) - Equities researchers at Cormark boosted their FY2027 earnings per share (EPS) estimates for kneat.com in a report issued on Thursday, October 9th. Cormark analyst G. Fairweather now forecasts that the company will post earnings per share of $0.09 for the year, up from their previous forecast of $0.08. The consensus estimate for kneat.com's current full-year earnings is ($0.12) per share.

Separately, Raymond James Financial dropped their price objective on kneat.com from C$7.50 to C$7.00 and set an "outperform" rating on the stock in a research report on Wednesday, August 6th. One investment analyst has rated the stock with a Strong Buy rating and two have assigned a Buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Buy" and a consensus price target of C$6.50.

kneat.com Trading Up 0.9%

kneat.com stock opened at C$5.90 on Monday. The company has a debt-to-equity ratio of 85.50, a current ratio of 1.43 and a quick ratio of 1.50. kneat.com has a one year low of C$4.54 and a one year high of C$7.25. The stock has a market capitalization of C$560.61 million, a PE ratio of 590.00, a price-to-earnings-growth ratio of 597.67 and a beta of 1.20. The business's fifty day moving average is C$5.63 and its 200 day moving average is C$5.97.

kneat.com Company Profile

kneat.com Inc is in the business of developing and marketing a software application for modelling regulated data-intensive processes for regulated industries, focusing on the life sciences industry. The company has developed Kneat Gx solution which provides management real-time visibility and control and increases product, quality, and compliance.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.